Clinical data | |
---|---|
Dependence liability | Moderate |
Routes of administration | Oral, sublingual, rectal |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C17H16N4S |
Molar mass | 308.40 g·mol−1 |
3D model (JSmol) | |
| |
|
Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated analog of the closely related etizolam.[1][2][3] The compound has been sold as a designer drug.[4][5][6][7]
Deschloroetizolam is classified and controlled as a hazardous substance in Sweden as of on October 15, 2015.[8]
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Sympatholytics (Antiadrenergics) |
|
Others | |
|
PAFR |
| ||||
---|---|---|---|---|---|
Others |
| ||||
|